The Wellbeing Program: A randomized controlled trial of internet based treatment of anxiety and depressio
Not Applicable
Completed
- Conditions
- Social phobia (an anxiety disorder)Panic disorder (with or without agoraphobia) (both anxiety disorders)Generalised anxiety disorder (an anxiety disorder)Major depressive disorder (a depressive disorder)Mental Health - DepressionMental Health - Anxiety
- Registration Number
- ACTRN12610000247077
- Lead Sponsor
- Clinical Research Unit for Anxiety and Depression (CRUfAD), School of Psychiatry, University of New South Wales
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Meet DSM-IV criteria for major depressive disorder, social phobia and/or panic disorder (with or without agoraphobia) and/or GAD
- Internet access + printer access
- Australian resident
- Males and females
Exclusion Criteria
- Current substance abuse/dependence
- Psychotic disorder
- Current or planned psychological treatment during study duration
- Change in medications during last 1 month or intended change during study duration
- Current use of benzodiazepines or beta-blockers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety is measured by the Generalised Anxiety Disorder 7 Item Scale (GAD-7)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Social phobia is measured by the Social Phobia Scale (SPS)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Social phobia is measured by the Social Interaction Anxiety Scale (SIAS)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment]
- Secondary Outcome Measures
Name Time Method euroticism is measured by using the NEO-Five Factor Inventory (NEO-FFI) Neuroticism scale[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Disability is measured by the Sheehan Disability Scale (SDS)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Psychological distress is measured by the Kessler 10-item scale (K-10)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Panic disorder is measured by the Panic Disorder Severity Rating Scale - Self Report Version (PDSS-SR)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Generalised anxiety disorder is measured by the Penn State Worry Questionnaire (PSWQ)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment];Symptoms and severity of depression is measured by the Patient Health Questionnaire-9 (PHQ-9)[Administered at pre-treatment, post-treatment, and at 3-months post-treatment]